Concepedia

C.R. Fairchild

CF

11

Publications

1.3K

Citations

11

H-Index

1987

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

National Cancer Institute

National Institutes of Health

C.R. Fairchild is an author at Bristol-Myers Squibb (United States) specializing in medicine, cell biology, and pharmacology.

Top concepts

Publications per year

1987–2005

11

Publications

11

Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells.

C.R. Fairchild, S. Percy Ivy, C. S. Kao-Shan et al. · PubMed · 1987 · 297 citations

, , +22

Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol).

B H Long, Joan M. Carboni, Arthur J. Wasserman et al. · PubMed · 1998 · 222 citations

, , +18

Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase.

B H Long, C.R. Fairchild · PubMed · 1994 · 209 citations

, , +21

Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas.

C.R. Fairchild, S. Percy Ivy, Thomas H. Rushmore et al. · Proceedings of the National Academy of Sciences · 1987 · 196 citations · Full text

, , +18

Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.

C.R. Fairchild, Jeffrey A. Moscow, Erin O’Brien et al. · Molecular Pharmacology · 1990 · 107 citations

Rows per page

1–5 of 11